Stay updated with breaking news from Lexaria Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
NEW YORK, Jan. 11, 2024 (GLOBE NEWSWIRE) -- NetworkNewsAudio – Lexaria Bioscience Corp. LEXX announces the availability of a broadcast titled, "Exciting New…
NEW YORK, Jan. 09, 2024 (GLOBE NEWSWIRE) -- via — Lexaria Bioscience Corp. LEXX today announces its placement in an editorial published by ("NNW"), one of 60+…
Lexaria Bioscience Corp. (NASDAQ:LEXX) shares lost ground Thursday. The global innovator in drug delivery platforms announces positive final results from its recently completed human Pilot Study #1 evaluating DehydraTECHTM technology for the oral delivery ...
Edesa Biotech (NASDAQ:EDSA – Get Free Report) and Lexaria Bioscience (NASDAQ:LEXX – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their profitability, institutional ownership, valuation, risk, analyst recommendations, earnings and dividends. Insider & Institutional Ownership 31.3% of Edesa […]
Lexaria Bioscience (NASDAQ:LEXX – Get Free Report) and Edesa Biotech (NASDAQ:EDSA – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, profitability, earnings, analyst recommendations, institutional ownership and dividends. Volatility & Risk Lexaria Bioscience has a […]